| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP1-18651 | |||
| Azide and BSA Free | NBP1-18651-0.02mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-29767-0.05mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-20160-0.2mg | |||
| Azide and BSA Free | NBP3-20160-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-20118-0.2mg | |||
| Azide and BSA Free | NBP3-20118-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81074-0.2mg | |||
| Azide and BSA Free | NBP2-81074-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81074-0.2mg | |||
| Azide and BSA Free | NBP2-81074-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-20118-0.2mg | |||
| Azide and BSA Free | NBP3-20118-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81039-0.025mg | |||
| Azide and BSA Free | NBP2-81039-0.2mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81069-0.2mg | |||
| Azide and BSA Free | NBP2-81069-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-20160-0.2mg | |||
| Azide and BSA Free | NBP3-20160-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-14157 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-08699 | |||
![Western Blot: MAPKAPK2 Antibody (7H4.2) [NBP2-29767] - Lysates from Hela were resolved by electrophoresis, transferred to PVDF and probed with anti-MAPKAPK2 (1 ug/mL). Proteins were visualized probed with using goat anti-mouse secondary antibody conjugated to HRP and chemiluminescence detection. Arrow indicates phosphorylated MAPKAPK2 (45 kDa).](http://images.novusbio.com/fullsize/MAPKAPK2-Antibody-7H4-2-Western-Blot-NBP2-29767-img0002.jpg "Western Blot: MAPKAPK2 Antibody (7H4.2) [NBP2-29767] - Lysates from Hela were resolved by electrophoresis, transferred to PVDF and probed with anti-MAPKAPK2 (1 ug/mL). Proteins were visualized probed with using goat anti-mouse secondary antibody conjugated to HRP and chemiluminescence detection. Arrow indicates phosphorylated MAPKAPK2 (45 kDa).")
![Insulin R/CD220 Antibody (83-7) [mFluor Violet 450 SE] [NBP2-81039MFV450] - Vial of mFluor Violet 450 conjugated antibody. mFluor Violet 450 is optimally excited at 406 nm by the Violet laser (405 nm) and has an emission maximum of 445 nm.](http://images.novusbio.com/fullsize/nbp2-81039mfv450_rabbit-insulin-r-cd220-mab-83-7-mfluor-violet-450-se-226202313132623.png "Insulin R/CD220 Antibody (83-7) [mFluor Violet 450 SE] [NBP2-81039MFV450] - Vial of mFluor Violet 450 conjugated antibody. mFluor Violet 450 is optimally excited at 406 nm by the Violet laser (405 nm) and has an emission maximum of 445 nm.")